{"product_id":"atlas-of-dermatology-inflammatory-infectious-and-tumoral-skin-diseases-9783030841065","title":"Atlas of Dermatology: Inflammatory, Infectious","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eDermatology is the science responsible for the study of the skin, mucous membranes (oral and genital) and cutaneous appendages, while dermatopathology focuses on its microscopic study. Although the two fields are closely related, in many cases the identification of dermatological diseases is mainly clinical and depends on the physician’s ability and experience. \u003c\/p\u003e  \u003cp\u003eThe purpose of this atlas, which collects over 900 clinical and histological photographs in high resolution, is to illustrate and describe the most frequent skin diseases on the basis of clinical cases. Offering a complete guide to the etiology, epidemiology, clinical features, histologic findings and diagnosis of the main skin diseases divided into three subgroups (inflammatory, infectious, or tumoral), it represents an invaluable resource for all medical students, residents, clinicians, and investigators learning dermatology.\u003c\/p\u003e\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eI.    \u003c\/b\u003e\u003cb\u003eINFLAMMATORY SKIN DISEASES\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e\u003cb\u003eChapter 1. Papulosquamous and eczematous dermatoses \u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e1. Dermatitis      or eczema\u003c\/p\u003e\u003cp\u003e\ta. Contact       dermatitis\u003c\/p\u003e\u003cp\u003e\t\ti. Allergic contact dermatitis\u003c\/p\u003e\u003cp\u003e\t\tii. Irritant contact dermatitis\u003c\/p\u003e\u003cp\u003e\tb. Atopic       dermatitis\u003c\/p\u003e\u003cp\u003e\tc. Aesteatotic       dermatitis\u003c\/p\u003e\u003cp\u003e\td. Nummular       dermatitis\u003c\/p\u003e\u003cp\u003e\te. Gravitational       Dermatitis\u003c\/p\u003e\u003cp\u003e\tf. Seborrheic       dermatitis\u003c\/p\u003e\u003cp\u003e\tg. Palmoplantar       vesicular dermatitis\u003c\/p\u003e\u003cp\u003e\t\ti. Ponfólix\u003c\/p\u003e\u003cp\u003e\t\tii. Chronic vesicle-bullous dermatitis of        the hands\u003c\/p\u003e\u003cp\u003e\t\tiii. Hyperkeratotic dermatitis of the hand\u003c\/p\u003e\u003cp\u003e\t\tiv. Ide reaction\u003c\/p\u003e\u003cp\u003e\th. Autosensitization       dermatitis\u003c\/p\u003e\u003cp\u003e\ti. Herpetic       eczema or varicelliform eruption of Kaposi\u003c\/p\u003e\u003cp\u003e\tj. Infectious       dermatitis\u003c\/p\u003e\u003cp\u003e\tk. Chronic       simple liquor\u003c\/p\u003e\u003cp\u003e\tl. Nodular       prurigo\u003c\/p\u003e\u003cp\u003e\tm. Plantar       Juvenile Dermatosis\u003c\/p\u003e  \u003cp\u003e2. Psoriasis\u003c\/p\u003e\u003cp\u003e\ta. Psoriasis       vulgaris or plaques\u003c\/p\u003e\u003cp\u003e\tb. Guttate       Psoriasis\u003c\/p\u003e\u003cp\u003e\tc. Pustular       psoriasis\u003c\/p\u003e\u003cp\u003e\t\ti. Located\u003c\/p\u003e\u003cp\u003e\t\t\t1. Palmoplantar         Pustulosis\u003c\/p\u003e\u003cp\u003e\t\t\t2. Continuous         acrodermatitis of Hallopau\u003c\/p\u003e\u003cp\u003e\t\tii. Generalized\u003c\/p\u003e\u003cp\u003e\t\t\t1. Acute         generalized pustulose (von Zumbusch)\u003c\/p\u003e\u003cp\u003e\t\t\t2. Annular         pustular\u003c\/p\u003e\u003cp\u003e\td. Inverse       psoriasis\u003c\/p\u003e\u003cp\u003e\te. Scalp       Psoriasis\u003c\/p\u003e\u003cp\u003e\tf. Genital       Psoriasis\u003c\/p\u003e\u003cp\u003e\tg. Erythrodermic       psoriasis\u003c\/p\u003e\u003cp\u003e\th. Nail       Psoriasis\u003c\/p\u003e\u003cp\u003e\ti. Psoriatic       arthropathy\u003c\/p\u003e\u003cp\u003e\tj. HIV-associated       psoriasis \u003c\/p\u003e \u003cp\u003e3. Lichen and lichenoid ​​reactions\u003c\/p\u003e\u003cp\u003e\ta. Lichen       planus\u003c\/p\u003e\u003cp\u003e\t\ti. Lichen planus pillar\u003c\/p\u003e\u003cp\u003e\t\tii. Oral lichen planus\u003c\/p\u003e\u003cp\u003e\t\tiii. Actinic lichen planus\u003c\/p\u003e\u003cp\u003e\t\tiv. Lichen planus pigmentosa\u003c\/p\u003e\u003cp\u003e\t\tv. Acute exanthematic flat lichen\u003c\/p\u003e\u003cp\u003e\t\tvi. Lichen inverse plane\u003c\/p\u003e\u003cp\u003e\t\tvii. Genital lichen planus\u003c\/p\u003e\u003cp\u003e\t\tviii. Hypertrophic lichen planus\u003c\/p\u003e\u003cp\u003e\t\tix. Bullous or pemphigid lichen planus\u003c\/p\u003e\u003cp\u003e\t\tx. Annular lichen planus\u003c\/p\u003e\u003cp\u003e\t\txi. Linear lichen planus\u003c\/p\u003e\u003cp\u003e\t\txii. Ungular lichen planus\u003c\/p\u003e\u003cp\u003e\t\txiii. Ulcerative lichen planus\u003c\/p\u003e\u003cp\u003e\tb. Lichenoid       reaction\u003c\/p\u003e\u003cp\u003e\tc. Fixed       pigmented erythema\u003c\/p\u003e\u003cp\u003e\td. Lichen       Crisp\u003c\/p\u003e\u003cp\u003e\te. Lichen       striatum\u003c\/p\u003e\u003cp\u003e\tf. Persistent       dyschromic erythema\u003c\/p\u003e\u003cp\u003e\tg. Chronic       Lichenoid Keratosis \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2. Other Papular, erythematous and scaly diseases\u003c\/b\u003e\u003c\/p\u003e1. Pityriasis      Lichenoid\u003cbr\u003e2. Pityriasis      liquenoid and acute varioliform\u003cbr\u003e3. Pityriasis,      chronic lichenoid\u003cbr\u003e4. Pityriasis      liquenoid leukcomelandermal\u003cbr\u003e5. Pityriasis      rubra pilaris\u003cbr\u003e6. Pityriasis      rosea\u003cbr\u003e7. Pityriasis      rotunda\u003cbr\u003e8. Granular      Parakeratosis \u003cbr\u003e \u003cp\u003e\u003cb\u003eChapter 3. Inflammatory diseases of pilose follicle\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e1. Alopecia\u003c\/p\u003e\ta. Non-scarring\t\ti. Alopecia        areata\t\tii. Alopecia        universalis\t\tiii. Alopecia        totalis\t\tiv. Patchy        alopecia areata\t\tv. Diffuse        Alopecia areata\t\tvi. Ophiasis        alopecia\t\tvii. Sisaifo        or reverse ophiasis alopecia\t\tviii. Androgenic        Alopecia\t\tix.Telogen        effluvium\t\tx. Trichotillomania\t\txi. Traction        alopecia\t\txii. Temporal        triangular alopecia\t\txiii. Lipedematous        Alopecia \tb. Scarring\t\ti. Central        centrifugal scarring alopecia\t\tii. Lichen        planus pilaris\t\t\t1. Classic         type\t\t\t2. Fibrosing         frontal alopecia\t\t\t3. Graham-Little-Piccardi         syndrome\t\tiii. Mucinous        Alopecia\t\tiv. Discoid        lupus\t\tv. Keloid        acne of the neck\t\tvi. Decalvating        folliculitis\t\tvii. Dissecting        folliculitis \u003cp\u003e2. Inflammatory folliculitis\u003c\/p\u003e\u003cp\u003e\ta. Pseudofolliculitis       of the beard\u003c\/p\u003e\u003cp\u003e\tb. Other       follicular disorders\u003c\/p\u003e\u003cp\u003e\tc. Suppurative       Hydradenitis \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 4. Inflammatory diseases of the sebaceous and apocrine glands\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Acne\u003c\/p\u003e\u003cp\u003e\ta. Degrees       of severity: mild, moderate and severe\u003c\/p\u003e\u003cp\u003e\tb. Acne       conglobata\u003c\/p\u003e\u003cp\u003e\tc. Acne       fulminans\u003c\/p\u003e\u003cp\u003e\td. Acne       necroticans\u003c\/p\u003e\u003cp\u003e\te. Acne       ointment or cosmetic\u003c\/p\u003e\u003cp\u003e\tf. Steroid       or medication-induced acne\u003c\/p\u003e\u003cp\u003e\tg. Hormonal       acne\u003c\/p\u003e\u003cp\u003e\th. Neonatal       acne\u003c\/p\u003e\u003cp\u003e\ti. Childhood       acne\u003c\/p\u003e\u003cp\u003e\tj. Excoriated       acne\u003c\/p\u003e\u003cp\u003e\tk. Occupational       acne\u003c\/p\u003e\u003cp\u003e\tl. Radiation       acne\u003c\/p\u003e\u003cp\u003e2. Rosacea\u003c\/p\u003e\u003cp\u003e\ta. Erythematous-telangiectatic       rosacea\u003c\/p\u003e\u003cp\u003e\tb. Papulopustular       rosacea\u003c\/p\u003e\u003cp\u003e\tc. Phymatous       rosacea\u003c\/p\u003e\u003cp\u003e\td. Ocular       rosacea\u003c\/p\u003e\u003cp\u003e\te. Rosaceiform       Dermatitis\u003c\/p\u003e\u003cp\u003e3. Perioral      dermatitis\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 5. Inflammatory skin diseases induced by drugs\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e1.\u003cb\u003e \u003c\/b\u003eDrug      reactions\u003c\/p\u003e\u003cp\u003e\ta. Morbilliform       rash\u003c\/p\u003e\u003cp\u003e\tb. Erythema       multiforme\u003c\/p\u003e\u003cp\u003e\tc. Steven-Johnson       syndrome\u003c\/p\u003e\u003cp\u003e\td. Toxic       epidermal necrolysis\u003c\/p\u003e\u003cp\u003e\te. Drug       reaction with eosinophilia and systemic symptoms\u003c\/p\u003e\u003cp\u003e\tf. Acute       generalized exanthematous pustulosis\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 6. Inflammatory diseases of the blood vessels with cutaneous involvement\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e1. Vasculitis\u003c\/p\u003e\u003cp\u003e\ta. Small       vessel vasculitis\u003c\/p\u003e\u003cp\u003e\t\ti. Leukocytoclastic vasculitis\u003c\/p\u003e\u003cp\u003e\t\tii. Henoch-Schonlein purple\u003c\/p\u003e\u003cp\u003e\t\tiii. Acute hemorrhagic edema of childhood\u003c\/p\u003e\u003cp\u003e\t\tiv. Erythema elevatum diutinum\u003c\/p\u003e\u003cp\u003e\tb. Mixed       vasculitis\u003c\/p\u003e\u003cp\u003e\t\ti. Cryoglobulinemia\u003c\/p\u003e\u003cp\u003e\t\tii. Associated with ANCA antibodies\u003c\/p\u003e\u003cp\u003e\t\tiii. Microscopic        polyangiitis\u003c\/p\u003e\u003cp\u003e\t\tiv. Wegener        granulomatosis\u003c\/p\u003e\u003cp\u003e\t\tv. Churg-Strauss        syndrome\u003c\/p\u003e\u003cp\u003e\tc. Secondary\u003c\/p\u003e\u003cp\u003e\t\ti. Septic        vasculitis\u003c\/p\u003e\u003cp\u003e\t\tii. Vasculitis        associated with inflammatory disorders (disseminated intravascular        coagulation)\u003c\/p\u003e\u003cp\u003e\td. Medium       vessel vasculitis\u003c\/p\u003e\u003cp\u003e\t\ti. Polyarteritis nodosa\u003c\/p\u003e\u003cp\u003e\te. Vasculitis       of large vessels\u003c\/p\u003e\u003cp\u003e\t\ti. Temporal arteritis\u003c\/p\u003e\u003cp\u003e\t\tii. Takayasu arteritis \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 7. Inflammatory diseases affecting melanocytes\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Inflammatory      diseases that occur with hyperpigmentation\u003c\/p\u003e\u003cp\u003e\ta. Post-inflammatory       hyperpigmentation\u003c\/p\u003e\u003cp\u003e\tb. Persistent       dyschromic erythema\u003c\/p\u003e\u003cp\u003e\tc. Lichen       planus pigmentosa\u003c\/p\u003e\u003cp\u003e\td. Melasma\u003c\/p\u003e\u003cp\u003e\te. Flagellated       Erythema\u003c\/p\u003e\u003cp\u003e\tf. Confluent       and reticulated papillomatosis of Gougerot and Carteaud\u003c\/p\u003e\u003cp\u003e\tg. Erythema       ab igne \u003c\/p\u003e\u003cp\u003e2. Inflammatory      diseases that occur with hypopigmentation\u003c\/p\u003e\u003cp\u003e\ta. Vitiligo\u003c\/p\u003e\u003cp\u003e\tb. Post-inflammatory       hypopigmentation\u003c\/p\u003e\u003cp\u003e\tc. Lichen       sclerosus and atrophic\u003c\/p\u003e\u003cp\u003e\td. Lichen       striatum\u003c\/p\u003e\u003cp\u003e\te. Pityriasis       alba \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 8. Bullous vesicular inflammatory diseases\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Pemphigus\u003c\/p\u003e\u003cp\u003e\ta. Pemphigus       vulgaris\u003c\/p\u003e\u003cp\u003e\t\ti. Mucocutaneous\u003c\/p\u003e\u003cp\u003e\t\tii. Vegetant\u003c\/p\u003e\u003cp\u003e\tb. Pemphigus       foliaceus\u003c\/p\u003e\u003cp\u003e\t\ti. Seborrheic or classic\u003c\/p\u003e\u003cp\u003e\t\tii. Fogo type selvagem\u003c\/p\u003e\u003cp\u003e\t\tiii. Senear syndrome - Usher\u003c\/p\u003e\u003cp\u003e\tc. Paraneoplastic       Pemphigus\u003c\/p\u003e\u003cp\u003e2. Dermatitis      herpetiformis\u003c\/p\u003e\u003cp\u003e3. Linear      IgA dermatosis\u003c\/p\u003e\u003cp\u003e4. Bullous      Pemphigoid\u003c\/p\u003e\u003cp\u003e5. Scarring      pemphigoid\u003c\/p\u003e\u003cp\u003e6. Pemphigoid      gestationis\u003c\/p\u003e\u003cp\u003e7. Epidermolysis      bullosa acquired\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 9. Inflammatory skin diseases presented as erythema, urticaria and purpura\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Urticaria\u003c\/p\u003e\u003cp\u003e\ta. Allergic       urticaria\u003c\/p\u003e\u003cp\u003e\tb. Physical       urticaria\u003c\/p\u003e\u003cp\u003e\tc. Cold and       heat urticaria\u003c\/p\u003e\u003cp\u003e\td. Cholinergic       urticaria\u003c\/p\u003e\u003cp\u003e\te. Vasculitic       urticaria \u003c\/p\u003e\u003cp\u003e2. Figurate      erythemas\u003c\/p\u003e\u003cp\u003e\ta. Annular       Erythema Centrifugal\u003c\/p\u003e\u003cp\u003e\tb. Erythema       gyratum repens\u003c\/p\u003e\u003cp\u003e\tc. Migratory       Necrolytic Erythema\u003c\/p\u003e\u003cp\u003e\td. Migratory       erythema\u003c\/p\u003e\u003cp\u003e\te. Married       Erythema \u003c\/p\u003e\u003cp\u003e3. Purples\u003c\/p\u003e\u003cp\u003e\ta. Purple       Pigments\u003c\/p\u003e\u003cp\u003e\t\ti. Progressive pigmentary dermatosis of        Schamberg\u003c\/p\u003e\u003cp\u003e\t\tii. Majocchi telangiectodes annular purpura\u003c\/p\u003e\u003cp\u003e\t\tiii. Gougerot and Blum pigmentary purpuraica        lichenoid dermatitis\u003c\/p\u003e\u003cp\u003e\t\tiv. Lichen aureus\u003c\/p\u003e\u003cp\u003e\t\tv. Pruritic purpura or eczematoid of        Doucas and Kapetanakis \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 10. Inflammatory connective tissue diseases\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Cutaneous      lupus\u003c\/p\u003e\u003cp\u003e\ta. Acute       lupus erythematosus\u003c\/p\u003e\u003cp\u003e\tb. Subacute       lupus erythematosus (SCLE)\u003c\/p\u003e\u003cp\u003e\t\ti. Annular SCLE\u003c\/p\u003e\u003cp\u003e\t\tii. Papulosquamous\/psoriasiform SCLE\u003c\/p\u003e\u003cp\u003e\tc. Chronic       cutaneous lupus\u003c\/p\u003e\u003cp\u003e\t\ti. Chronic discoid lupus erythematosus\u003c\/p\u003e\u003cp\u003e\t\t\t1. Located\u003c\/p\u003e\u003cp\u003e\t\t\t2. Disseminated\u003c\/p\u003e\u003cp\u003e\t\tii. Hypertrophic\u003c\/p\u003e\u003cp\u003e\t\tiii. Lupus panniculitis\u003c\/p\u003e\u003cp\u003e\t\tiv. Lupus Childblain\u003c\/p\u003e\u003cp\u003e\t\tv. Lupus tumidus\u003c\/p\u003e\u003cp\u003e\t\tvi. Bullous lupus\u003c\/p\u003e\u003cp\u003e\td. Other       variants\u003c\/p\u003e\u003cp\u003e\t\ti. Rowell syndrome\u003c\/p\u003e\u003cp\u003e\t\tii. Neonatal Lupus \u003c\/p\u003e\u003cp\u003e2. Dermatomyositis\u003c\/p\u003e\u003cp\u003e3. Scleroderma\u003c\/p\u003e\u003cp\u003e4. Morphea\u003c\/p\u003e\u003cp\u003e5. Scleredema\u003c\/p\u003e\u003cp\u003e6. Recurrent      Polychondritis\u003c\/p\u003e\u003cp\u003e7. Rheumatoid      arthritis\u003c\/p\u003e\u003cp\u003e8. Graft      versus host disease \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 11. Granulomatous inflammatory diseases\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e1.\u003cb\u003e \u003c\/b\u003eSarcoidosis\u003c\/p\u003e\u003cp\u003e2. Annular      granuloma\u003c\/p\u003e\u003cp\u003e3. Lipoid      Necrobiosis\u003c\/p\u003e\u003cp\u003e4. Giant      cell annular elastotic granuloma\u003c\/p\u003e\u003cp\u003e5. Crohn's      disease of the skin\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cb\u003eChapter 12. Inflammatory diseases induced by ultraviolet radiation\u003c\/b\u003e 1. Immunologically      mediated dermatoses\ta. Polymorphic       luminic eruption\tb. Actinic       prurigo\tc. Chronic       actinic dermatitis \td. Solar       urticaria\te. Hydroa       vacciniform2. Photodermatosis      secondary to exogenous agents\ta. Photocontact       dermatitis\tb. Phototoxic       and photoallergic dermatitis 3. Photodermatosis      secondary to endogenous agents\ta. Congenital       erythropoietic porphyria\tb. Erythropoietic       Protoporphyria\tc. Cutaneous       porphyria takes\td. Pseudoporphyria\te. Hepatoerythropoietic       porphyria 4. Diseases      caused by defects in DNA repair\ta. Xeroderma       pigmentoso\tb. Trichotiodystrophy 5. Photogravure      disorders (present in each respective section)\ta. Lupus erythematosus\tb. Dermatomyositis\tc. Rosacea\td. Atopic       dermatitis\te. Seborrheic       dermatitis \u003cp\u003e\u003cb\u003eChapter 13. Neutrophilic and eosinophilic inflammatory diseases\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Neutrophilic      Infiltrates\u003c\/p\u003e\u003cp\u003e\ta. Acute       febrile neutrophilic dermatosis (Sweet syndrome)\u003c\/p\u003e\u003cp\u003e\tb. Pyoderma       gangrenosum\u003c\/p\u003e\u003cp\u003e\tc. Subcorneal       pustular dermatosis (Sneddon-Wilkinson disease)\u003c\/p\u003e\u003cp\u003e\td. Behcet's       disease\u003c\/p\u003e\u003cp\u003e\te. Neutrophilic       dermatosis of the back of the hands\u003c\/p\u003e\u003cp\u003e\tf. Ecrine       Neutrophilic Hydradenitis\u003c\/p\u003e\u003cp\u003e\tg. Rheumatoid       Neutrophilic Dermatitis \u003c\/p\u003e\u003cp\u003e2. Eosinophilic      Infiltrates\u003c\/p\u003e\u003cp\u003e\ta. Facial       granuloma\u003c\/p\u003e\u003cp\u003e\tb. Eosinophilic       pustular folliculitis\u003c\/p\u003e\u003cp\u003e\tc. Eosinophilic       cellulitis\u003c\/p\u003e\u003cp\u003e\td. Eosinophilic       Fasciitis \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 14. Inflammatory diseases of subcutaneous cell tissue\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Lobular      Panniculitis\u003c\/p\u003e\u003cp\u003e\ta. Indurated       Bazin Erythema or Nodular Vasculitis\u003c\/p\u003e\u003cp\u003e\tb. Pancreatic       panniculitis\u003c\/p\u003e\u003cp\u003e\tc. Scleredema       neonatorum\u003c\/p\u003e\u003cp\u003e\td. Fat       necrosis of the newborn\u003c\/p\u003e\u003cp\u003e\te. Post-steroid       panniculitis\u003c\/p\u003e\u003cp\u003e\tf. Lupus       panniculitis\u003c\/p\u003e\u003cp\u003e\tg. Panniculitis       due to dermatomyositis\u003c\/p\u003e\u003cp\u003e\th. Lipodystrophic       Panniculitis\u003c\/p\u003e\u003cp\u003e\ti. Cold       panniculitis\u003c\/p\u003e\u003cp\u003e\tj. Sclerosing       Lipogranuloma\u003c\/p\u003e\u003cp\u003e\tk. Paniculitis       from injected substances\u003c\/p\u003e\u003cp\u003e\tl. Lipodermatosclerosis\u003c\/p\u003e\u003cp\u003e2. Septal      panniculitis\u003c\/p\u003e\u003cp\u003e\ta. Paniculitis       due to alpha 1 antitrypsin deficiency\u003c\/p\u003e\u003cp\u003e\tb. Erythema       nodosum \u003c\/p\u003e \u003cp\u003e\u003cb\u003eII. INFECTIOUS SKIN DISEASES\u003c\/b\u003e \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eChapter 15. Bacterial infections\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Staphylococcal      and streptococcal infections\u003c\/p\u003e\u003cp\u003e\ta. Impetigo\u003c\/p\u003e\u003cp\u003e\tb. Ectima\u003c\/p\u003e\u003cp\u003e\tc. Erysipelas\u003c\/p\u003e\u003cp\u003e\td. Cellulitis\u003c\/p\u003e\u003cp\u003e\te. Acute       lymphangitis\u003c\/p\u003e\u003cp\u003e\tf. Necrotizing       Fasciitis\u003c\/p\u003e\u003cp\u003e\tg. Folliculitis,       boil, anthrax\u003c\/p\u003e\u003cp\u003e\th. Acute       paronychia\u003c\/p\u003e\u003cp\u003e2. Staphylococcal      and streptococcal toxin syndromes\u003c\/p\u003e\u003cp\u003e\ta. Scalded       skin syndrome\u003c\/p\u003e\u003cp\u003e\tb. Toxic       Shock Syndrome\u003c\/p\u003e\u003cp\u003e\tc. Toxic       Streptococcal Shock Syndrome\u003c\/p\u003e\u003cp\u003e\td. Scarlet       fever\u003c\/p\u003e\u003cp\u003e\te. Erysipeloid\u003c\/p\u003e\u003cp\u003e\tf. Corinebacterial       Infections\u003c\/p\u003e\u003cp\u003e\tg. Erythrasma\u003c\/p\u003e\u003cp\u003e\th. Keratolysis       punctata\u003c\/p\u003e\u003cp\u003e3. Gram-negative      infections\u003c\/p\u003e\u003cp\u003e\ta. Gangrenous       Ectima\u003c\/p\u003e\u003cp\u003e\tb. Infections       caused by Bartonella\u003c\/p\u003e\u003cp\u003e\tc. Disease       cat scratch\u003c\/p\u003e\u003cp\u003e\td. Bacillary       Angiomatosis\u003c\/p\u003e\u003cp\u003e\te. Bacteria       previously classified as fungi\u003c\/p\u003e\u003cp\u003e\tf. Actinomycosis\u003c\/p\u003e\u003cp\u003e\tg. Nocardiosis \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 16. Mycobacterial Infections\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Leprosy\u003c\/p\u003e\u003cp\u003e\ta. Cutaneous       tuberculosis\u003c\/p\u003e\u003cp\u003e\tb. Tubercle       chancre\u003c\/p\u003e\u003cp\u003e\tc. Bazin       indurated erythema\u003c\/p\u003e\u003cp\u003e\td. Escrofuloderma\u003c\/p\u003e\u003cp\u003e\te. Lichen       scrofulosorum\u003c\/p\u003e\u003cp\u003e\tf. Lupus       vulgaris\u003c\/p\u003e\u003cp\u003e2. Acute      disseminated miliary tuberculosis\u003c\/p\u003e\u003cp\u003e3. Papulonecrotic      tuberculosis\u003c\/p\u003e\u003cp\u003e4. Tuberculosis      verrucous complexion\u003c\/p\u003e\u003cp\u003e5. Non-tuberculous      mycobacteria \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter  17. Fungal infections\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Superficial      mycoses\u003c\/p\u003e\u003cp\u003e\ta. Dermatophytosis       or ringworm\u003c\/p\u003e\u003cp\u003e\t\ti. Tinea        capitis\u003c\/p\u003e\u003cp\u003e\t\tii. Tinea        Faciei\u003c\/p\u003e\u003cp\u003e\t\tiii. Ringworm        of the beard\u003c\/p\u003e\u003cp\u003e\t\tiv. Tinea        corporis\u003c\/p\u003e\u003cp\u003e\t\tv. Inguinal        ringworm\u003c\/p\u003e\u003cp\u003e\t\tvi. Tinea        Pedis\u003c\/p\u003e\u003cp\u003e\t\tvii. Tinea        Incognita\u003c\/p\u003e\u003cp\u003e\tb. Cutaneous       Candidiasis\u003c\/p\u003e\u003cp\u003e\t\ti. Oral        and perioral candidiasis\u003c\/p\u003e\u003cp\u003e\t\tii. Pseudomembranous\u003c\/p\u003e\u003cp\u003e\t\tiii. Perleche        (angular cheilitis)\u003c\/p\u003e\u003cp\u003e\t\tiv. Atrophic        oral candidiasis\u003c\/p\u003e\u003cp\u003e\t\tv. Hypertrophic        oral candidiasis\u003c\/p\u003e\u003cp\u003e\t\tvi. Genital        candidiasis\u003c\/p\u003e\u003cp\u003e\t\tvii. Candidiasic        Intertrigo\u003c\/p\u003e\u003cp\u003e\t\tviii. Candidatic        Perionixix\u003c\/p\u003e\u003cp\u003e\tc. Onychomycosis\u003c\/p\u003e\u003cp\u003e\td. Pityriasis       versicolor\u003c\/p\u003e\u003cp\u003e\te. Black       ringworm\u003c\/p\u003e\u003cp\u003e2. Deep      mycoses\u003c\/p\u003e\u003cp\u003e\ta. Chromomycosis\u003c\/p\u003e\u003cp\u003e\tb. Mycetoma\u003c\/p\u003e\u003cp\u003e\tc. Sporotrichosis\u003c\/p\u003e\u003cp\u003e\td. Lobomycosis \u003c\/p\u003e\u003cp\u003e3. Systemic      mycoses\u003c\/p\u003e\u003cp\u003e\ta. Blastomycosis\u003c\/p\u003e\u003cp\u003e\tb. Coccidiodomycosis\u003c\/p\u003e\u003cp\u003e\tc. Histplasmosis\u003c\/p\u003e\u003cp\u003e\td. Paracoccidiodomycosis\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 18. Virus infections\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Enterovirus\u003c\/p\u003e\u003cp\u003e\ta. Hand-foot-mouth       disease\u003c\/p\u003e\u003cp\u003e\tb. Herpangina\u003c\/p\u003e\u003cp\u003e\tc. Pseudoangiomatosis       eruptive \u003c\/p\u003e\u003cp\u003e2. Herpesvirus      (VHH)\u003c\/p\u003e\u003cp\u003e\ta. VHH 1       AND 2: Herpes simplex virus (HSV) types 1 and 2\u003c\/p\u003e\u003cp\u003e\t\ti. Herpetic        gingivostomatitis\u003c\/p\u003e\u003cp\u003e\t\tii. Genital        herpes\u003c\/p\u003e\u003cp\u003e\t\tiii. Herpetic        eczema\u003c\/p\u003e\u003cp\u003e\t\tiv. Herpetic        Panadizo\u003c\/p\u003e\u003cp\u003e\t\tv. Herpes        gladiatorum\u003c\/p\u003e\u003cp\u003e\t\tvi. Herpetic        folliculitis\u003c\/p\u003e\u003cp\u003e\t\tvii. Herpes        simplex hypertrophic\u003c\/p\u003e\u003cp\u003e\tb. VHH 3:       Varicella zoster virus\u003c\/p\u003e\u003cp\u003e\t\ti. Chickenpox\u003c\/p\u003e\u003cp\u003e\t\tii. Congenital        chickenpox\u003c\/p\u003e\u003cp\u003e\t\tiii. Herpes        zoster\u003c\/p\u003e\u003cp\u003e\tc. VHH 4:       epstein-barr virus\u003c\/p\u003e\u003cp\u003e\t\ti. Hairy        leukoplakia\u003c\/p\u003e\u003cp\u003e\t\tii. Ulcers        of lipschütz\u003c\/p\u003e\u003cp\u003e\t\tiii. Hydroa        vacciniforme\u003c\/p\u003e\u003cp\u003e\td. VHH 5:       Cytomegalovirus\u003c\/p\u003e\u003cp\u003e\te. VHH 6:       Herpesvirus type 6\u003c\/p\u003e\u003cp\u003e\t\ti. Exanthem        Subitum\u003c\/p\u003e\u003cp\u003e\tf. VHH 7:       Herpes virus type 7\u003c\/p\u003e\u003cp\u003ei. Pityriasis        rosea\u003c\/p\u003e\u003cp\u003e\tg. VHH 8:       Herpesvirus type 8\u003c\/p\u003e\u003cp\u003e\t\ti. Kaposi's        sarcoma \u003c\/p\u003e\u003cp\u003e3. Papillomavirus\u003c\/p\u003e\u003cp\u003e\ta. Vulgar       warts\u003c\/p\u003e\u003cp\u003e\tb. Flat       warts\u003c\/p\u003e\u003cp\u003e\tc. Accumulated       condyloma\u003c\/p\u003e\u003cp\u003e\td. Bowenoid       Papulosis\u003c\/p\u003e\u003cp\u003e\te. Heck       disease \u003c\/p\u003e\u003cp\u003e4. Poxvirus\u003c\/p\u003e\u003cp\u003e\ta. Molluscum       contagiosum\u003c\/p\u003e\u003cp\u003e\tb. Orf       nodule\u003c\/p\u003e\u003cp\u003e\tc. Milkman's       Node\u003c\/p\u003e\u003cp\u003e5. Other      virus diseases\u003c\/p\u003e\u003cp\u003e\ta. Chikungunya\u003c\/p\u003e\u003cp\u003e\tb. Infectious       erythema\u003c\/p\u003e\u003cp\u003e\tc. Unilateral       laterothoracic rash\u003c\/p\u003e\u003cp\u003e\td. Roseola\u003c\/p\u003e\u003cp\u003e\te. Rubella\u003c\/p\u003e\u003cp\u003e\tf. Measles\u003c\/p\u003e\u003cp\u003e\tg. Gianotti-crosti       syndrome \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 19. Sexually transmitted diseases\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Syphilis\u003c\/p\u003e\u003cp\u003e2. Gonorrhea\u003c\/p\u003e\u003cp\u003e3. Chancroid\u003c\/p\u003e\u003cp\u003e4. Venereal      lymphogranuloma\u003c\/p\u003e\u003cp\u003e5. Inguinal      granuloma \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 20. Infections by parasites\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Protozoa\u003c\/p\u003e\u003cp\u003e\ta. Leishmaniasis\u003c\/p\u003e\u003cp\u003e2. Helminths\u003c\/p\u003e\u003cp\u003e\ta. Cutaneous       Migrans Larva\u003c\/p\u003e\u003cp\u003e\tb. Filariasis\u003c\/p\u003e\u003cp\u003e3. Infestations\u003c\/p\u003e\u003cp\u003e\ta. Scabiosis\u003c\/p\u003e\u003cp\u003e\tb. Pediculosis\u003c\/p\u003e\u003cp\u003e\tc. Tungiasis\u003c\/p\u003e\u003cp\u003e\td. Cutaneous       myiasis \u003c\/p\u003e \u003cp\u003e\u003cb\u003eIII. NEOPLASTIC SKIN DISEASES\u003c\/b\u003e \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eChapter 21. Benign neoplasms\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Benign      epidermal tumors and proliferations\u003c\/p\u003e\u003cp\u003e\ta. Seborrheic       keratosis\u003c\/p\u003e\u003cp\u003e\tb. Lichenoid       Keratosis\u003c\/p\u003e\u003cp\u003e\tc. Estucokeratosis\u003c\/p\u003e\u003cp\u003e\td. Poroqueratosis\u003c\/p\u003e\u003cp\u003e\te. Papular       nigrans dermatosis\u003c\/p\u003e\u003cp\u003e\tf. Verruciform       Acrokeratosis\u003c\/p\u003e\u003cp\u003e\tg. Cutaneous       horn\u003c\/p\u003e\u003cp\u003e\th. Clear       cell acanthoma\u003c\/p\u003e\u003cp\u003e\ti. Acanthoma       Acanthoma\u003c\/p\u003e\u003cp\u003e\tj. Epidermolytic       acanthoma\u003c\/p\u003e\u003cp\u003e\tk. Large       cell acanthoma\u003c\/p\u003e\u003cp\u003e\tl. Inverted       follicular keratosis\u003c\/p\u003e\u003cp\u003e\tm. Epidermal       nevus\u003c\/p\u003e\u003cp\u003e\tn. Linear       Verrucous Epidermal Nevus\u003c\/p\u003e\u003cp\u003e\to. Flegel       disease (hyperkeratosis lenticularis perstans)\u003c\/p\u003e\u003cp\u003e\tp. Comedogenic       Nevus\u003c\/p\u003e\u003cp\u003e\tq. Acanthosis       nigricans\u003c\/p\u003e\u003cp\u003e\tr. Confluent       and cross-linked papillomatosis\u003c\/p\u003e\u003cp\u003e\ts. Clear       cell papulosis \u003c\/p\u003e\u003cp\u003e2. Cysts      with stratified squamous epithelium\u003c\/p\u003e\u003cp\u003e\ta. Epidermoid       cyst\u003c\/p\u003e\u003cp\u003e\tb. Winer's       dilated pore and pillar sheath cliff\u003c\/p\u003e\u003cp\u003e\tc. Millium       Cyst\u003c\/p\u003e\u003cp\u003e\td. Triquilemal       cyst\u003c\/p\u003e\u003cp\u003e\te. Proliferating       epidermoid cyst\u003c\/p\u003e\u003cp\u003e\tf. Cyst       hair vellus\u003c\/p\u003e\u003cp\u003e\tg. Steatocistoma\u003c\/p\u003e\u003cp\u003e\th. Keratocysts\u003c\/p\u003e\u003cp\u003e\ti. Follicular       Hybrid Cyst\u003c\/p\u003e\u003cp\u003e\tj. Dermoid       cyst\u003c\/p\u003e\u003cp\u003e\tk. Pre-auricular       cyst\u003c\/p\u003e\u003cp\u003e\tl. Pilonidal       cyst \u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 22. Skin adnexal neoplasms \u003c\/b\u003e\u003c\/p\u003e1. Hair      follicle nevus\u003cbr\u003e2. Trichofolliculoma\u003cbr\u003e3. Sebaceous      Nevus\u003cbr\u003e4. Tricoepitelioma      \/ tricoblastoma\u003cbr\u003e5. Desmoplastic      trichoepithelioma\u003cbr\u003e6. Pilomatricoma\u003cbr\u003e7. Pilmatrical      carcinoma\u003cbr\u003e8. Triquilemoma\u003cbr\u003e9. Triquilemal      Carcinoma\u003cbr\u003e10. Tumor of      the follicular infundibulum\u003cbr\u003e11. Tricoadenoma\u003cbr\u003e12. Proliferating      pillar tumor\u003cbr\u003e13. Sebaceous      gland hyperplasite\u003cbr\u003e14. Sebaceous      adenoma-sebaceous epithelioma, sebaceoma\u003cbr\u003e15. Sebaceous      carcinoma\u003cbr\u003e16. Syringoma\u003cbr\u003e17. Poroma\u003cbr\u003e18. Hydradenoma\u003cbr\u003e19. Apocrine      adenoma\u003cbr\u003e20. Papilliferous      Syringocystodenoma\u003cbr\u003e21. Spiroadenoma\u003cbr\u003e22. Cylindroma\u003cbr\u003e23. Porocarcinoma\u003cbr\u003e24. Ecrine      Nevus\u003cbr\u003e25. Sirigofibroadenoma\u003cbr\u003e26. Papillary      adenoma and adenocarcinoma \u003cbr\u003e \u003cp\u003e\u003cb\u003eChapter 23. Muscle, adipose tissue and cartilaginous neoplasms\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Leiomyoma\u003cbr\u003e2. Leiomyosarcoma\u003c\/p\u003e\u003cp\u003e3. Smooth      muscle hamartoma\u003c\/p\u003e4. Lipoma\u003cbr\u003e5. Angiolipoma\u003cbr\u003e6. Hibernoma\u003cbr\u003e7. Superficial      lipomatous nevus\u003cbr\u003e8. Lipoblastoma\u003cbr\u003e9. Liposarcoma\u003cbr\u003e10. Chondrome \u003cbr\u003e \u003cp\u003e\u003cb\u003eChapter 24. Vascular malformations\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e1. Capillaries:\u003c\/p\u003e\u003cp\u003e\ta. Klippel       syndrome - Trenaunay\u003c\/p\u003e\u003cp\u003e\tb. Porto       wine stain\u003c\/p\u003e\u003cp\u003e2. Arterial:      Angiohistiocytoma\u003c\/p\u003e\u003cp\u003e\ta. Telangiectasias\u003c\/p\u003e\u003cp\u003e\tb. Cutist       congenital telangiectatic marmorata\u003c\/p\u003e\u003cp\u003e\tc. Angiokeratomas\u003c\/p\u003e\u003cp\u003e3. Venous:\u003c\/p\u003e\u003cp\u003e\ta. Venous       Cephalic Malformation\u003c\/p\u003e\u003cp\u003e\tb. Glomus-venous\u003c\/p\u003e\u003cp\u003e4. Lymphatic:      hemangiolinphangioma\u003c\/p\u003e\u003cp\u003e5. Other      vascular malformations:\u003c\/p\u003e\u003cp\u003e\ta. Anemic       nevus\u003c\/p\u003e\u003cp\u003e\tb. Venous       lake\u003c\/p\u003e\u003cp\u003e\tc. Cherry       anigoma\u003c\/p\u003e\u003cp\u003e\td. Telangiectatic       granuloma\u003c\/p\u003e\u003cp\u003e\t6. Infantile      hemangioma\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 25. Fibrous and fibrohystiocytic proliferations of skin and tendons\u003c\/b\u003e \u003c\/p\u003e1. Dermatofibromas\u003cbr\u003e2. Angiofibromas\u003cbr\u003e3. Loose      fibroma\u003cbr\u003e4. Superficial      fibromatosis: Juvenile plantar fibromatosis: Plantar fibromatosis      Ledderhose disease\u003cbr\u003e5. Acral      fibrokeratoma\u003cbr\u003e6. Superficial      acral fibromxoma\u003cbr\u003e7. Pleomorphic      skin fibroma\u003cbr\u003e8. Giant      cell tumors of the tendon sheath\u003cbr\u003e9. Tendon      sheath fibroma\u003cbr\u003e10. Nodular      fasciitis\u003cbr\u003e11. Connective      tissue nevus\u003cbr\u003e12. Children's      digital fibroma\u003cbr\u003e13. Childhood      Myofibromatosis\u003cbr\u003e14. Aponeurotic      calcifying fibroma\u003cbr\u003e15. Atypical      fibroxanthoma\u003cbr\u003e16. Dermatofibrosarcoma      protuberans\u003cbr\u003e17. Giant      cell fibroblastoma \u003cbr\u003e \u003cp\u003e\u003cb\u003eChapter 26. Congenital melanocytic nevus and acquired\u003c\/b\u003e\u003c\/p\u003e1. Congenital      melanocytic nevus\u003cbr\u003e2. Acquired      melanocytic nevus: union, compound, intradermal\u003cbr\u003e3. Ungular      matrix melanocytic nevus\u003cbr\u003e4. Spilus      nevus\u003cbr\u003e5. Miescher's      Nevus\u003cbr\u003e6. Spitz      nevus\u003cbr\u003e7. Meyerson      Nevus\u003cbr\u003e8. Sutton      nevus or halo nevus\u003cbr\u003e9. Becker's      Nevus\u003cbr\u003e10. Dysplastic      or Clark's Nevus\u003cbr\u003e11. Blue      nevus \u003cbr\u003e \u003cp\u003e\u003cb\u003eChapter 27. Neural and neuroendocrine neoplasms\u003c\/b\u003e\u003c\/p\u003e1. Neurofibroma\u003cbr\u003e2 Neurothecoma\u003cbr\u003e3. Schwanoma\u003cbr\u003e4. Granular      cell tumor\u003cbr\u003e5. Perineuroma\u003cbr\u003e6. Tumor of      the malignant peripheral nerve sheath\u003cbr\u003e7. Merkel      cell carcinoma\u003cbr\u003e8. Nasal glioma\u003cb\u003e \u003c\/b\u003e\u003cbr\u003e \u003cp\u003e\u003cb\u003eChapter 28. Disorders of cells of langerháns and macrophages\u003c\/b\u003e\u003c\/p\u003e1. Langerhans      cell histiocytosis\u003cbr\u003e2. Histiocytosis      of non-Langerhans cells\u003cbr\u003e3. Xanthomas \u003cbr\u003e \u003cp\u003e\u003cb\u003eChapter 29. Malignant neoplasms\u003c\/b\u003e\u003c\/p\u003e1. Actinic      Keratosis\u003cbr\u003e2. Adenoescamous      carcinoma\u003cbr\u003e3. Basal      cell carcinoma\u003cbr\u003e4. Basescamosal      carcinoma\u003cbr\u003e5. Keratoacanthoma\u003cbr\u003e6. Bowen's      disease\u003cbr\u003e7. Queyrat      Erythroplasia\u003cbr\u003e8. Squamous      cell carcinoma\u003cbr\u003e9. Bowen's      disease\u003cbr\u003e10. Mastocytosis\u003cbr\u003e11. Melanoma\u003cbr\u003e12. Skin      metastasis\u003cbr\u003e13. Paget's      disease 14. T-cell      Lymphoma\ta. Lymphomatoid       papulosis\tb. Leukemia       \/ T-cell lymphoma\tc. Mycosis       fungoides\td. Primary       gamma \/ delta cutaneous T-cell lymphoma\te. CD8       positive aggressive epidermotropic cytotoxic T cell lymphoma\tf. Nasal       extraganglionic T \/ NK cell lymphoma\tg. Paniculitis       like T-cell lymphoma15. B-cell      Lymphoma\ta. Primary       cutaneous B-cell lymphoma of the marginal zone\u003cbr\u003e\tb. Primary       cutaneous central follicle lymphoma\u003cbr\u003e\tc. Diffuse       giant B-cell cutaneous lymphoma type leg\u003cbr\u003e\td. Intravascular       diffuse giant B-cell lymphoma\u003cbr\u003e\te. B cell       precursor lymphoblastic leukemia \/ lymphoma \u003cbr\u003e \u003cp\u003e\u003cb\u003eChapter 30. Other lymphoproliferative disorders\u003c\/b\u003e \u003c\/p\u003e1. Plasmocytoid      dendritic cell neoplasia\u003cbr\u003e2. Jessner      lymphocytic infiltrate\u003cbr\u003e3. Lymphocytoma      cutis\u003cbr\u003e4. Extramedullary      hematopoiesis\u003cbr\u003e5. Leukemia      complexion\u003cbr\u003e6. Hodgkin's      disease\u003cbr\u003e7. Lymphomatoid      granulomatosis\u003cbr\u003e\u003col\u003e\u003c\/ol\u003e\u003cb\u003e\u003c\/b\u003e","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":49415647592791,"sku":"9783030841065","price":208.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783030841065.jpg?v=1730527641","url":"https:\/\/bookcurl.com\/products\/atlas-of-dermatology-inflammatory-infectious-and-tumoral-skin-diseases-9783030841065","provider":"Book Curl","version":"1.0","type":"link"}